Corcept Therapeutics Inc
Change company Symbol lookup
Select an option...
CORT Corcept Therapeutics Inc
CVS CVS Health Corp
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc

Health Care : Pharmaceuticals | Small Cap Growth
Company profile

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). As of December 31, 2016, it had discovered three structurally distinct series of selective cortisol modulators, all of which share mifepristone's affinity for GR but, unlike mifepristone, do not bind to the progesterone receptor. It is conducting two clinical trials of its selective cortisol modulator, CORT125134. One trial is investigating CORT125134 as a treatment for patients with Cushing syndrome. The second trial is investigating the combination of CORT125134 and nab-paclitaxel (Celgene Corporation's Abraxane) to treat patients with solid-tumor cancers.

Closing Price
Day's Change
-0.30 (-1.67%)
B/A Size
Day's High
Day's Low

10-day average volume:

UPDATE: Airline stocks led higher by Delta Air after travel demand rises to post-COVID-19 high

3:07 pm ET September 14, 2020 (MarketWatch)

By Tomi Kilgore, MarketWatch

Delta's stock paces Dow transports gainers after $6.5 billion debt offering plans, and raised target by analyst

Airline stocks were broadly higher Monday, led by Delta Air Lines Inc., after more positive travel demand data, with a surge in the broader stock market also providing support.

The U.S. Global Jets exchange-traded fund(JETS) hiked up 2.0% in afternoon trading, while the Dow Jones Transportation Average gained 0.5%, as all six of its airline components gained ground. Meanwhile, the Dow Jones Industrial Average rallied 310 points, or 1.1%.

The gains come as data from the Transportation Security Administration ( showed that an average of 738,038 people went through TSA travel security checkpoints each day for the week ended Sept. 13. That's above the 715,145 daily average of the previous week, which includes most of the Labor Day holiday weekend, which tends to see a boost in travel demand. Read more about Labor Day travel demand (

Last week's daily average was also the highest since the week ended March 22, and is well above the post-COVID-19 pandemic low of 97,799 for the week ended April 19.

The gain in the daily average the past two weeks comes after the average fell for two-straight weeks during the second half of August.

Delta Air's stock(DAL) rose 3.2% to pace the sector's gainers. The air carrier said earlier that it and its SkyMiles IP Ltd. subsidiary are planning to raise $6.5 billion ( through a bond offering and by entering a senior secured term loan facility.

The company also said that while it is eligible to receive $5.4 billion in emergency relief through the Coronavirus Aid, Relief and Economic Securities (CARES) Act payroll support program, it doesn't intend to participate in the program.

For the quarter ending September, Delta said it expects system capacity to be down about 60% from a year ago, with domestic capacity down 50% and international capacity down 80%.

BofA Securities analyst Andrew Didora raised his price target on Delta's stock to $36 from $31, but kept his rating at neutral.

Among other Dow transport components, shares of Southwest Airlines Co.(LUV) advanced 2.8%, American Airlines Group Inc.(AAL) climbed 1.8%, JetBlue Airways Corp.(JBLU) rose 2.1%, Alaska Air Group Inc.(ALK) climbed 2.2% and United Airlines Holdings Inc.(UAL) rallied 1.8%.

Elsewhere, shares of Spirit Airlines Inc.(SAVE) surged 2.8%, Hawaiian Airlines parent Hawaiian Holdings Inc.(HA) gained 1.2% and Allegiant Travel Co.(ALGT) rose 2.2%.

BofA Securities analyst Andrew Didora said he views airline stocks as options on a recovery from the COVID-19 crisis, and prefers those with longer duration in the form of liquidity runways.

Didora said Southwest and Alaska Air, which he rates buy, have liquidity into 2023, while underperform-rated American and Hawaiian have the shortest runways, until August 2021.

He raised his stock price targets for Alaska Air to $55 from $50, for JetBlue to $13 from $12, for Spirit Airlines to $12 from $10 and for Allegiant Travel to $147 from $130. He kept his targets for American at $, for United at $40, for Southwest at $44 and for Hawaiian at $14.

-Tomi Kilgore; 415-439-6400;

(END) Dow Jones Newswires

September 14, 2020 15:07 ET (19:07 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.